Prevalence of vitamin D deficiency and consequences for PTH reference values.
Deckers MM, de Jongh RT, Lips PT, Penninx BW, Milaneschi Y, Smit JH, van Schoor NM, Blankenstein MA, Heijboer AC
Purpose
Conclusion
Studies (1)
Purpose
The purpose of this study was to determine the effects of serum 25OHD levels and other preacquisition variables on PTH levels in EDTA plasma from the Longitudinal Aging Study Amsterdam (LASA) and the Netherlands Study of Depression and Anxiety (NESDA) cohorts. The specimens from the LASA cohort were obtained in 2002 after patients had a light breakfast and stored at -20 degrees C until analysis in 2009. Specimens from the NESDA cohort were collected after an overnight fast and stored at -80 degrees C from between 2004 and 2007 until analysis in 2011. Each cohort was analyzed separately. 25OHD levels were measured by radioimmunoassay (RIA) among the LASA cohort and by isotope dilution/online solid-phase extraction liquid chromatography/tandem mass spectrometry (ID-XLC-MS/ MS) among the NESDA cohort.
Summary of Findings
For both the LASA and NESDA cohorts, EDTA plasma PTH reference values were lower when serum 25OHD levels were 50 nmol/L or greater than when they were < 50 nmol/L. PTH references values were higher among the specimens from the LASA cohort than the NESDA cohort, but the authors state this was not a factor of different 25OHD assays between the two cohorts. The authors also state that no clinically significant differences in PTH levels were noted based on patient age, gender, or BMI and that neither these nor creatinine levels were confounding variables in the noted relationship between 25OHD and PTH levels.
Biospecimens
FluidPlasmaFluidBloodPreservation Types
FrozenDiagnoses
Not specifiedPlatforms
PeptideClinical chemistry/auto analyzerSmall moleculeRadioimmunoassaySmall moleculeLC-MS or LC-MS/MSPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Preaquisition Biomarker level 25ODH < 50 nmol/L25ODH concentration of 50 nmol/L or greaterA range of creatinine levelsPreaquisition Patient age 18-65 years (NESDA)55-65 years (LASA)Preaquisition Patient body mass index 16.3-47.3 (NESDA)17.9-45 (LASA)Preaquisition Patient gender FemaleMaleStorage Storage duration 4-7 years7 yearsRadioimmunoassay Specific Technology platform ID-XLC-MS/ MS